Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate, and heparin.
Hoppensteadt
D
D
Department of Pathology, Loyola University Medical Center, Maywood, Illinois 60153.
Racanelli
A
A
Walenga
J M
JM
Fareed
J
J
D000818:Animals; D001780:Blood Coagulation Tests; D002807:Chondroitin; D003871:Dermatan Sulfate / Q000627:therapeutic use* / Q000633:toxicity; D005343:Fibrinolytic Agents / Q000627:therapeutic use* / Q000633:toxicity; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced*; D006493:Heparin / Q000627:therapeutic use* / Q000633:toxicity; D006497:Heparan Sulfate / Q000627:therapeutic use* / Q000633:toxicity; D008297:Male; D011817:Rabbits; D013927:Thrombosis / Q000517:prevention & control*
D002807:Chondroitin; D003871:Dermatan Sulfate; D005343:Fibrinolytic Agents; D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate